Tissue-specific Knockout

The key restriction comes from where Cre recombinase is produced. A tissue-specific promoter drives Cre expression in the selected tissue or cell type, so Cre recognizes the two loxP sites and excises the DNA between them in those cells. This links promoter activity to the location of gene disruption, rather than applying the change across the entire organism.

The loxP sites act as positional boundaries for recombination. When Cre is active, it targets those paired sequences and removes the intervening segment, disabling the gene in the affected cells. Without this arrangement, tissue-restricted Cre expression would not provide the same defined genetic switch for the selected target. Thus, loxP placement is central to conditional control.

A whole-body knockout can combine effects from many tissues, making it difficult to identify where a gene normally acts. Restricting gene loss to one tissue preserves the gene's function elsewhere, helping researchers attribute observed biological changes to the selected tissue or cell type. This separation supports clearer analysis of physiology, development, and disease mechanisms.

In cells where the tissue-specific promoter does not activate Cre, the loxP-flanked gene is not excised under the described strategy. Its function therefore remains available outside the selected tissue or cell type. This preserved activity creates an important internal contrast between cells with tissue-restricted gene disruption and those retaining the target gene.

The target gene is first arranged with loxP sequences flanking the DNA region intended for excision. A Cre recombinase gene is then placed under the control of a promoter active in the tissue or cell type of interest. In cells where that promoter functions, Cre removes the intervening target sequence, producing the intended localized gene disruption.

This approach can reveal whether a gene's role differs among tissues or cell types without eliminating its function throughout the organism. Researchers can use that distinction to investigate tissue-specific contributions to development, physiology, and disease mechanisms. The resulting evidence can also clarify whether a gene or its tissue-specific activity represents a potential therapeutic target.